Caution:At present, there are occasional discrepancies in the display of intellectual property rights holders and their representatives. We are working on a solution.
see.ip - Details for VERWENDUNG VON IL-1 INHIBITOREN UND TNF ANTAGONISTEN ZUM TEIL IN KOMBINATION MIT RECOMBINANTEN HUMANEN ERYTHROPOIETINEN ZUR BEHANDLUNG VON ANAEMIE
Details for 2001992582
Up to date per 12.06.2026
Actions
Details for 2001992582
Title / Product Name
VERWENDUNG VON IL-1 INHIBITOREN UND TNF ANTAGONISTEN ZUM TEIL IN KOMBINATION MIT RECOMBINANTEN HUMANEN ERYTHROPOIETINEN ZUR BEHANDLUNG VON ANAEMIE
Status
Deleted
Protection Type
European Patent
(AT-) Application Number
2001992582
EP Publication Number
1330260
E-Number
666079
Language
EN
PCT Number
US01046205
Publication Date
30.07.2003 A
07.05.2014 B1
Registration Date
07.05.2014
AT Publication Date
15.05.2014
Application Date
30.10.2001
Registration Number
-
Priorities
31.10.2000
US
244792 P
02.10.2001
US
969739
IPC
A61K 38/18 20060101AFI20131111BHEP
Maximum Duration of Protection
30.10.2021
Owner
AMGEN INC.One Amgen Center Drive Thousand Oaks, CA 91320-1799US
Representative
No representatives present
Inventor
KAY, Jonathan62 Olde Field Road Newton Center, ME 02459-2734US
MCCABE, Dorothy10708 Pimlico Moorpark, CA 93021US
NEWMARK, Richard998 Via Candella Newbury Park, CA 91320US
COCCIA, Marco, A.3505 Bean Creek Road Scotts Valley, California 95066US